Evidence map›Paper›PMID 39016024›Full record

Trial reportCannabis and cannabinoid research2024

Topical Cannabidiol for Established Chemotherapy-Induced Neuropathy: A Pilot Randomized Placebo-Controlled Trial.

Stacy D'Andre, Paul Novotny, Camille Walters, Susie Lewis-Peters, Stephan Thomé, Cindy S Tofthagen, Karthik V Giridhar, Charles Loprinzi

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Cannabis and cannabinoid research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Stacy D'AndreDepartment of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0003-4726-7223
Paul NovotnyDepartment of Statistics, Mayo Clinic, Rochester, Minnesota, USA.
Camille WaltersDepartment of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA.
Susie Lewis-PetersDepartment of Nursing, Mayo Clinic, Rochester, Minnesota, USA.
Stephan ThoméDepartment of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Cindy S TofthagenDepartment of Nursing, Mayo Clinic, Jacksonville, Florida, USA.
Karthik V GiridharDepartment of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Charles LoprinziDepartment of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI AKHILESH PANDEY · 1985 to 2026
$151.3M
NCI NIH HHS P30 CA015083
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsCannabidiolPeripheral Nervous System DiseasesAdministration, TopicalAdultAgedCross-Over StudiesDouble-Blind MethodFemaleHumansMaleMiddle AgedPilot ProjectsTreatment OutcomeAntineoplastic AgentsCannabidiolcannabidiolchemotherapy-induced neuropathyclinical trialtopical

Identifiers

PMID39016024
PMCPMC11685298

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.